960 SAN ANTONIO ROAD, PALO ALTO, CA
Scilex Holding Secures Exclusive License for RWA Tokenization in Genomics and Drug Data
Termination of Common Stock Purchase Agreement with Tumim Stone Capital
Changes in Board, Management or Compensation
News, Material Contracts
Material Contracts, Completing Asset Acquisition or Sale, Reg. FD
Material Contracts, Completing Asset Acquisition or Sale, Unregistered Sales of Equity Securities, Reg. FD, Other Events
Scilex Holding Announces $20M Private Placement at $16/share
Q2
Q1
Amended Annual Report
FY 2024
Q4
Notice of Late Filing for Quarterly Report
Prospectus filed pursuant to Rule 424(b)(3)
Notice of Exempt Offering of Securities
PRE 14A
Definitive Proxy Statement
PRER14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Post-Effective Amendment to Registration Statement